Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich, Kings College London Ink Deal on miRNA Test

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sigma Life Science today announced a licensing deal with King's College London for the development and commercialization of technology to identify and validate miRNA targets in research and clinical diagnostics.

The technology was developed at the division of cancer studies at King's College. No further details about the technology or terms of the deal were disclosed.

miRNAs are critical regulators of gene expression in eukaryotic cells, and aberrant expression in miRNAs has been implicated in numerous disease states, making them important targets in clinical research in oncology, wound healing, and infectious disease, according to Sigma Life Science, the biological products and services research business of Sigma-Aldrich. However, the specific targets of most miRNAs are unknown, and current methods of identifying miRNA targets are "laborious and inefficient" relying on computer algorithms and validation by in vitro assays, the company added.

In a statement, Joop Gaken, lead researcher on the project at King's College, said that the method developed by him and his colleagues "is expected to enable the straightforward identification of target genes that are strongly regulated by a given miRNA, helping to elucidate important gene regulation events in vivo."

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.